Targeted News Service

International Myeloma Foundation's Black Swan Research Initiative Presents Data and Results of Phase 2 ASCENT Cure Trial at EHA 2026 Congress
June 19, 2026

NORTH HOLLYWOOD, California, June 19 -- The International Myeloma Foundation issued the following news:

* * *

International Myeloma Foundation's Black Swan Research Initiative Presents Data and Results of Phase 2 ASCENT Cure Trial at EHA 2026 Congress

Quadruplet Dara-KRd combination demonstrates high rates of response in high-risk smoldering myeloma patients similar to that observed in NDMM; MRD negativity maintained in nearly two-thirds of patients, w . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form